𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Chemosensitization by STI571 targeting the platelet-derived growth factor/platelet-derived growth factor receptor-signaling pathway in the tumor progression and angiogenesis of gastric carcinoma

✍ Scribed by Ryungsa Kim; Manabu Emi; Koji Arihiro; Kazuaki Tanabe; Yoko Uchida; Tetsuya Toge

Publisher
John Wiley and Sons
Year
2005
Tongue
English
Weight
795 KB
Volume
103
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Increased sensitivity to the platelet-de
Increased sensitivity to the platelet-derived growth factor (PDGF) receptor inhibitor STI571 in chemoresistant glioma cells is associated with enhanced PDGF-BB-mediated signaling and STI571-induced Akt inactivation
✍ Tiziana Servidei; Anna Riccardi; Maurizio Sanguinetti; Carlo Dominici; Riccardo 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 377 KB

## Abstract The platelet‐derived growth factor receptor (PDGFR) is a tyrosine kinase, implicated in the development and progression of different tumors, including gliomas. Chemoresistance is a common feature of malignant gliomas. Since receptor tyrosine kinases contribute to chemoresistance in tumo

Imatinib mesylate for targeting the plat
Imatinib mesylate for targeting the platelet-derived growth factor β receptor in combination with fluorouracil and leucovorin in patients with refractory pancreatic, bile duct, colorectal, or gastric cancer—A dose-escalation Phase I trial
✍ Salah-Eddin Al-Batran; Akin Atmaca; Eberhard Schleyer; Claudia Pauligk; Christia 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 188 KB

## Abstract ## BACKGROUND. In previous experimental models, because of its ability to inhibit the activity of platelet‐derived growth factor β receptor, imatinib decreased the interstitial fluid pressure and improved the delivery and efficacy of anticancer drugs, including fluorouracil. The object